Skip to search.
 TSX Down 0.17% TSX Ventures Down 0.39%

Novavax, Inc. (NVAX)

-NasdaqGS
8.07 Down 0.16(1.94%) Apr 17, 4:00PM EDT
|After Hours : 8.07 0.00 (0.00%) Apr 17, 4:22PM EDT
Add to Portfolio
Prev Close:8.23
Open:8.17
Bid:8.07 x 1000
Ask:8.25 x 1000
1y Target Est:11.04
Beta:1.33
Earnings Date:May 5 - May 11 (Est.)
Day's Range:7.95 - 8.25
52wk Range:3.70 - 9.95
Volume:6,936,225
Avg Vol (3m):5,038,300
Market Cap:1.93B
P/E (ttm):N/A
EPS (ttm):-0.37
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Comparison

Symbol% ChgMkt Cap
NVAXDown 1.94%1.93B
MRKDown 1.66%161.44B
NVSDown 0.82%245.76B

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):64.11
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-15) :-0.47
Quarterly EPS Est (Mar-15) :-0.11
Mean Recommendation*:1.4
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Novavax, Inc., a clinical-stage vaccine company, focuses on discovering, developing, and commercializing recombinant nanoparticle vaccines and adjuvants. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback